1.Tawil R., Van Der Maarel SM. Facioscapulohumeral muscular dystrophy. Muscle Nerve. 2006. 34:1–15.
Article
2.Arahata K., Ishihara T., Fukunaga H., Orimo S., Lee JH., Goto K, et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve Suppl. 1995. 2:S56–S66.
Article
3.Munsat TL., Piper D., Cancilla P., Mednick J. Inflammatory myopathy with facioscapulohumeral distribution. Neurology. 1972. 22:335–347.
Article
4.Wulff JD., Lin JT., Kepes JJ. Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome. Ann Neurol. 1982. 12:398–401.
Article
5.Bacq M., Telerman-Toppet N., Coërs C. Familial myopathies with restricted distribution, facial weakness and inflammatory changes in affected muscles. J Neurol. 1985. 231:295–300.
Article
6.van Deutekom JC., Bakker E., Lemmers RJ., van der Wielen MJ., Bik E., Hofker MH, et al. Evidence for subtelomeric exchange of 3.3 kb tandemly repeated units between chromosomes 4q35 and 10q26: implications for genetic counselling and etiology of FSHD1. Hum Mol Genet. 1996. 5:1997–2003.
Article
7.Dalakas MC., Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003. 362:971–982.
Article
8.Bao SS., King NJ., dos Remedios CG. Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon. Immunol Cell Biol. 1990. 68(Pt 4):235–241.
9.Michaelis D., Goebels N., Hohlfeld R. Constitutive and cytokine-in-duced expression of human leukocyte antigens and cell adhesion molecules by human myotubes. Am J Pathol. 1993. 143:1142–1149.
10.Molnár M., Diószeghy P., Mechler F. Inflammatory changes in facioscapulohumeral muscular dystrophy. Eur Arch Psychiatry Clin Neurosci. 1991. 241:105–108.
Article